The CD8 CTL, CD8 TCM, and GZMK+ effector CD8 T-cell subsets of patients with IgG4-RD were associated with significantly enhanced responses to IFN-γ, antigen processing and presentation, and lymphocyte differentiation (Figure 5F). This evidence concerns the gene GZMK and immunoglobulin G4-related sclerosing disease.